Therapeutic Equivalence (Orange Book)

Therapeutic equivalence is the FDA determination that approved pharmaceutical equivalents meet its criteria, including bioequivalence, and are expected to have the same clinical effect and safety under labeled conditions. Orange Book A ratings include AB and several other codes.

Get personalized explanations
💡

Exam Tip

FDA A ratings establish therapeutic equivalence within the relevant group; B ratings do not. Match numbered codes such as AB1/AB2. Ratings inform substitution without overriding state law or the prescription. Bioequivalence does not allow tablets to contain 80-125% of labeled drug.

What Is Therapeutic Equivalence?

Therapeutic equivalence means that a generic drug can be expected to produce the same clinical effect and safety profile as its brand-name counterpart. The FDA publishes therapeutic equivalence evaluations in "Approved Drug Products with Therapeutic Equivalence Evaluations," commonly known as the Orange Book.

Requirements for Therapeutic Equivalence

A drug must meet ALL of the following:

RequirementDescription
Pharmaceutical equivalenceSame active ingredient, dosage form, strength, and route of administration
BioequivalenceMeets the applicable FDA evidence standard; this is not a rule that every patient concentration or tablet potency can range from 80% to 125%
Adequate labelingCompliant with FDA labeling requirements
cGMP complianceManufactured under current Good Manufacturing Practice
Approved safety/effectiveness and qualityApproved products meet applicable identity, strength, purity, and quality standards

Orange Book Rating Codes

Code PrefixMeaning
AFDA considers the products therapeutically equivalent within the relevant group; substitution follows state law and prescription restrictions
BFDA does not currently consider the products therapeutically equivalent

Common A-Rated Codes

CodeMeaning
ABBioequivalence demonstrated; most common for substitution
AAConventional dosage forms without known or suspected bioequivalence problems
APInjectable aqueous solutions
ATTopical products
ANSolutions and powders for aerosolization in general-use delivery systems

Common B-Rated Codes

CodeMeaning
BCExtended-release products NOT shown to be bioequivalent
BDDocumented bioequivalence problems
BPPotential bioequivalence problems
BXInsufficient data for determination

Generic Substitution Rules

FactorDetails
AB-ratedMay support substitution under state law; compare products within the same numbered AB group, when present
B-ratedCannot be automatically substituted
State lawsMost states require or permit generic substitution for AB-rated products
Narrow therapeutic index (NTI)Some states restrict substitution for NTI drugs (warfarin, levothyroxine, phenytoin)

Pharmacy Technician's Role

  • Check Orange Book ratings when selecting generic alternatives
  • Verify the applicable FDA therapeutic equivalence rating and product group before any substitution allowed by state law
  • Apply correct DAW code on insurance claims
  • Refer B-rated products, different numbered AB groups, and state-law restrictions to the pharmacist; do not assume interchangeability

Exam Alert

Therapeutic equivalence is tested in both the Dispensing Process and Drugs/Drug Therapy domains. Key points: A ratings establish FDA therapeutic equivalence within the relevant group, while B ratings do not. State substitution law, prescriber restrictions, and specific product rules still apply.

Study This Term In

Related Terms

Where shall we go next?

Your AI study companion · 10 free interactions a day

Stay Updated

Get free exam tips and study guides delivered to your inbox.

Free exam tips & study guides. Unsubscribe anytime.